SCHEMBL7991402

SCHEMBL7991402

O=c1[nH]c(-c2ccccc2)nc2ncn(Cc3ccc(Cl)cc3)c12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.54
ALDH1A1 P00352 3/20 0.54
KMT2A Q03164 1/20 0.53
HPGD P15428 2/20 0.51
TNKS O95271 1/20 0.46
GUSB P08236 1/20 0.46
TNKS2 Q9H2K2 1/20 0.46
PARP2 Q9UGN5 1/20 0.46
BRD4 O60885 1/20 0.44
BRD2 P25440 1/20 0.44
BRD3 Q15059 1/20 0.44
BRDT Q58F21 1/20 0.44
TSHR P16473 1/20 0.44
CYP11B1 P15538 2/20 0.43
CYP11B2 P19099 2/20 0.43
ADORA3 P0DMS8 1/20 0.43
KDR P35968 1/20 0.43
MAPK1 P28482 2/20 0.42
HTT P42858 1/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984453 0.95 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1KMT2AHPGDTNKS
SCHEMBL7975265 0.93 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1KMT2AHPGDTNKS
SCHEMBL7986518 0.89 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDTNKS
SCHEMBL7984716 0.89 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDTNKS
SCHEMBL7988662 0.89 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDADORA3
SCHEMBL7974010 0.87 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDHTT
SCHEMBL7985702 0.86 HPGD (0.50) SMN1; SMN2ALDH1A1KMT2AHPGDTNKS
SCHEMBL7974486 0.86 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1KMT2AHPGDTNKS
SCHEMBL7987948 0.86 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1KMT2AHPGDTNKS
SCHEMBL7974445 0.86 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1KMT2AHPGDBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed